Merck Closes Out Canadian Vioxx Claims For Up To $36.5M

By Rachel Slajda (January 19, 2012, 7:49 PM EST) -- Merck & Co. Inc. will pay up to CA$36.9 million (US$36.5 million) to settle a series of Canadian class actions over its marketing of the painkiller Vioxx, which the drugmaker pulled from shelves in 2004 after studies showed the drug doubled the risk of stroke and heart attack....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!